Bone Research is a premier open-access journal published by SpringerNature, dedicated to advancing the understanding of bone biology and its related disciplines. Established in 2013 and based in the United Kingdom, this journal has quickly ascended to the forefront of scientific inquiry, evidenced by its esteemed Q1 rankings in 2023 across multiple categories including Endocrinology, Diabetes and Metabolism, Histology, and Physiology. With a commendable impact reflected in its Scopus ranks—positioned #2 in Histology, #9 in Endocrinology, and #8 in Physiology—Bone Research serves as a vital platform for researchers, healthcare professionals, and students alike to share and access cutting-edge findings. Since adopting an open-access model in 2014, the journal has empowered an expansive audience by facilitating immediate availability of high-quality research. This aligns with its commitment to foster innovation and collaboration within the fields it encompasses. As it converges its efforts from 2013 to 2024, Bone Research remains a critical resource for those looking to deepen their investigation into bone health and diseases, ensuring its place as a leader in promoting scientific excellence.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Diabetes Epidemiology and Management, published by Elsevier, is an innovative open-access journal that has been addressing the critical issues surrounding diabetes since its inception in 2021. This journal integrates a comprehensive exploration of the epidemiology, prevention, and management of diabetes, making it a pivotal resource within the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine. With a digital presence represented by E-ISSN 2666-9706, it currently holds a commendable position in the academic landscape, categorized in the Q3 quartile for both Endocrinology and Internal Medicine as per the 2023 metrics. The journal aims to enhance understanding and promote research on diabetes, offering authors a platform to share their findings with a global audience. Researchers, professionals, and students alike can benefit from this essential resource, which is dedicated to advancing the knowledge base and improving clinical practices in diabetes management. With open access options since 2021, the journal ensures that vital research is widely accessible, driving innovation and collaboration in the fight against diabetes.

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

JOMR-Journal of Oral & Maxillofacial Research is a leading open-access journal dedicated to the dissemination of high-quality research in the field of oral and maxillofacial sciences. Published by UAB Stilus Optimus, this journal has been a vital resource for researchers, clinicians, and educators since its inception in 2010, promoting innovative findings and insights that advance our understanding of oral health and surgical procedures. With an ISSN of 2029-283X, JOMR publishes a diverse range of articles covering clinical studies, case reports, and reviews, establishing itself as an essential platform for sharing knowledge among professionals in dentistry and maxillofacial surgery. The journal's commitment to open access ensures that its cutting-edge research is freely available to a global audience, enhancing collaboration and fostering academic dialogue within the field. As an important contributor to the scholarly community, JOMR plays a crucial role in shaping future research and practice in oral and maxillofacial care.

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

BONE, published by Elsevier Science Inc, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Endocrinology, Diabetes and Metabolism, Histology, and Physiology. Since its inception in 1985 and continuing to 2025, this journal has consistently provided high-quality research, evidenced by its impressive Q1 category rankings and strong performance in Scopus metrics—ranking #7 in Histology and achieving notable percentiles in related fields. With a commitment to advancing knowledge and understanding in bone biology and associated pathological conditions, BONE serves as an essential platform for researchers and professionals aiming to contribute to the discourse in skeletal health and disease. While it is not an open-access publication, the journal ensures a broad dissemination of pivotal research findings, making it a critical asset for academics and practitioners devoted to fostering advancements in medical sciences.

Osteologie is a distinguished journal published by GEORG THIEME VERLAG KG, focusing on advancing knowledge in the field of osteology and related medical disciplines. With an ISSN of 1019-1291 and E-ISSN 2567-5818, this journal plays a pivotal role in disseminating research that addresses bone health, osteoporotic conditions, and skeletal disorders. Despite its current ranking in Q4 within the broad category of Medicine (miscellaneous), and a Scopus rank placing it at the 15th percentile, Osteologie serves as a platform for emerging research and opinions in a multidisciplinary context. Curating content from 1999 to 2024, it provides valuable insights to researchers, professionals, and students keen on enhancing their understanding of bone health and its implications on overall well-being. With access options available through various academic channels, this journal remains an essential resource for those committed to the exploration and advancement of osteological science.

CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.